TEAPOT Study Multisite

Part of paid clinical trials in Davis, California.

Sponsor
The University of Texas Health Science Center at San Antonio
Study ID
NCT07565753
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Hemorrhage, Surgical
  • Tonsillar Bleeding

Eligibility Criteria

Sex
ALL
Age
2 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Tranexamic Acid Injectable Product — DRUG
    Participants will receive three doses of TXA 500 mg (5 mL of TXA 100mg/ml) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.
  • Normal Saline — OTHER
    Participants will receive three 5 ml doses of placebo (normal saline) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.

Study Details

After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot. If this mist works well, it could help kids get better by making sure they don't have to go back for more surgery or need blood from someone else. Not having another surgery is good because it means kids won't have to sleep under medicine again, which can sometimes be risky for their brains and breathing, and they won't feel as scared or hurt.

Key Dates

Start date
Jul 31, 2026
Status verified
Jan 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2028

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Nebulized Tranexamic Acid
    Subjects will be adminstered nebulized TXA post-tonsillectomy if they return to the emergency room with hemorrhage after surgery
  • Placebo Comparator: Nebulized Saline
    Subjects will be adminstered nebulized saline post-tonsillectomy if they return to the emergency room with hemorrhage after surgery

Primary Outcome Measure

Number of patients enrolled per month [ Time Frame: Baseline to 18 months (or duration of study approximately 18 months) ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of California at Davis Medical CenterDavisCalifornia95819
Daniel Nishijima, MD
Hasbro Childrens' HospitalProvidenceRhode Island02903
Thomas Chun, MD
401-444-6680
University HospitalSan AntonioTexas78229
Andrew D Meyer, MD, MS
210-562-5816
Stephanie Perez
210-450-8973

Find similar trials in Davis, CA

Related Studies